Side-by-side financials for CTNM and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CTNM | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$59.98M | - |
| SEC filings | 156 | 1,004 |
Full pages: Contineum Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.